122 related articles for article (PubMed ID: 12891468)
1. [Plasma VEGF levels are increased in women with severe preeclampsia or HELLP syndrome].
Bussen S; Rieger L; Sütterlin M; Dietl J
Z Geburtshilfe Neonatol; 2003; 207(3):101-6. PubMed ID: 12891468
[TBL] [Abstract][Full Text] [Related]
2. Influence of the vascular endothelial growth factor on the development of severe pre-eclampsia or HELLP syndrome.
Bussen S; Bussen D
Arch Gynecol Obstet; 2011 Sep; 284(3):551-7. PubMed ID: 20941502
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor (VEGF) polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analyses.
Nagy B; Savli H; Molvarec A; Várkonyi T; Rigó B; Hupuczi P; Rigó J
Clin Chim Acta; 2008 Mar; 389(1-2):126-31. PubMed ID: 18167313
[TBL] [Abstract][Full Text] [Related]
4. Association between tumor necrosis factor (TNF)-alpha G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restriction.
Molvarec A; Jermendy A; Nagy B; Kovács M; Várkonyi T; Hupuczi P; Prohászka Z; Rigó J
Clin Chim Acta; 2008 Jun; 392(1-2):52-7. PubMed ID: 18396154
[TBL] [Abstract][Full Text] [Related]
5. Concentrations of estrogens in patients with preeclampsia.
Zeisler H; Jirecek S; Hohlagschwandtner M; Knöfler M; Tempfer C; Livingston JC
Wien Klin Wochenschr; 2002 Jun; 114(12):458-61. PubMed ID: 12422581
[TBL] [Abstract][Full Text] [Related]
6. [Intercellular adhesion molecular 1, a diagnostic serum marker in chorioamnionitis, pre-eclampsia and HELLP syndrome].
Steinborn A; Sohn C; Scharf A; Geka F; Haas S; Kaufmann M
Z Geburtshilfe Neonatol; 2000; 204(4):140-5. PubMed ID: 11008336
[TBL] [Abstract][Full Text] [Related]
7. Plasma renin activity and aldosterone serum concentration are decreased in severe preeclampsia but not in the HELLP-syndrome.
Bussen SS; Sütterlin MW; Steck T
Acta Obstet Gynecol Scand; 1998 Jul; 77(6):609-13. PubMed ID: 9688237
[TBL] [Abstract][Full Text] [Related]
8. Correlation of maternal serum high-sensitive C-reactive protein levels with biochemical and clinical parameters in preeclampsia.
Kumru S; Godekmerdan A; Kutlu S; Ozcan Z
Eur J Obstet Gynecol Reprod Biol; 2006 Feb; 124(2):164-7. PubMed ID: 16054746
[TBL] [Abstract][Full Text] [Related]
9. PAPP-A levels of late pregnancy in preeclampsia and HELLP syndrome.
Atis A; Aydin Y; Basol E; Kaleli S; Turgay F; Goker N
Arch Gynecol Obstet; 2012 Jan; 285(1):45-9. PubMed ID: 21533533
[TBL] [Abstract][Full Text] [Related]
10. Vascular reactivity in patients with preeclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome.
Fischer T; Schneider MP; Schobel HP; Heusser K; Langenfeld M; Schmieder RE
Am J Obstet Gynecol; 2000 Dec; 183(6):1489-94. PubMed ID: 11120516
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of neopterin, tumor necrosis factor-alpha and Interleukin-6 in preeclampsia: relationship with disease severity.
Ozler A; Turgut A; Sak ME; Evsen MS; Soydinc HE; Evliyaoglu O; Gul T
Eur Rev Med Pharmacol Sci; 2012 Nov; 16(12):1707-12. PubMed ID: 23161044
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of adhesion molecules (sVCAM-1) in serum of nonpregnant women, normotensive pregnant women and in patients with pregnancy complications].
Kunkel S; Briese V; Rohde E; Friese K
Zentralbl Gynakol; 1999; 121(9):426-9. PubMed ID: 10522374
[TBL] [Abstract][Full Text] [Related]
13. Plasma markers of angiogenesis in pregnancy induced hypertension.
Nadar SK; Karalis I; Al Yemeni E; Blann AD; Lip GY
Thromb Haemost; 2005 Nov; 94(5):1071-6. PubMed ID: 16363251
[TBL] [Abstract][Full Text] [Related]
14. Vasoactivity to and endogenous release of vascular endothelial growth factor in the in vitro perfused human placental lobule from pregnancies complicated by preeclampsia.
Brownbill P; Mills TA; Soydemir DF; Sibley CP
Placenta; 2008 Nov; 29(11):950-5. PubMed ID: 18845336
[TBL] [Abstract][Full Text] [Related]
15. Total and Fetal Circulating Cell-Free DNA, Angiogenic, and Antiangiogenic Factors in Preeclampsia and HELLP Syndrome.
Muñoz-Hernández R; Medrano-Campillo P; Miranda ML; Macher HC; Praena-Fernández JM; Vallejo-Vaz AJ; Dominguez-Simeon MJ; Moreno-Luna R; Stiefel P
Am J Hypertens; 2017 Jul; 30(7):673-682. PubMed ID: 28338787
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF.
Manau D; Fábregues F; Peñarrubia J; Creus M; Carmona F; Casals G; Jiménez W; Balasch J
Hum Reprod; 2007 Mar; 22(3):669-75. PubMed ID: 17079244
[TBL] [Abstract][Full Text] [Related]
17. Reduced pseudocholinesterase activity in patients with HELLP syndrome.
Lurie S; Sadan O; Oron G; Fux A; Boaz M; Ezri T; Golan A; Bar J
Reprod Sci; 2007 Feb; 14(2):192-6. PubMed ID: 17636231
[TBL] [Abstract][Full Text] [Related]
18. The expression and concentration of CD40 ligand in normal pregnancy, preeclampsia, and hemolytic anemia, elevated liver enzymes and low platelet count (HELLP) syndrome.
Azzam HA; Abousamra NK; Goda H; El-Shouky R; El-Gilany AH
Blood Coagul Fibrinolysis; 2013 Jan; 24(1):71-5. PubMed ID: 23241952
[TBL] [Abstract][Full Text] [Related]
19. [Measuring the concentration of various plasma and placenta extract proteolytic and vascular factors in pregnant patients with HELLP syndrome, pre-/eclampsia and highly pathologic Doppler flow values].
Kolben M; Lopens A; Bläser J; Huber A; Frank M; Wilhelm O; Wilhelm S; Schneider KT; Ulm K; Tschesche H
Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():126-31. PubMed ID: 8672911
[TBL] [Abstract][Full Text] [Related]
20. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
Rajakumar A; Michael HM; Rajakumar PA; Shibata E; Hubel CA; Karumanchi SA; Thadhani R; Wolf M; Harger G; Markovic N
Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
